225 related articles for article (PubMed ID: 22916233)
1. Optimal therapy for adults with Langerhans cell histiocytosis bone lesions.
Cantu MA; Lupo PJ; Bilgi M; Hicks MJ; Allen CE; McClain KL
PLoS One; 2012; 7(8):e43257. PubMed ID: 22916233
[TBL] [Abstract][Full Text] [Related]
2. Langerhans Cell Histiocytosis in the Pediatric Population: Treatment of Isolated Craniofacial Lesions.
Gargano F; Welch JJ; Klinge PM; Sullivan SR; Taylor HO
J Craniofac Surg; 2019 Jun; 30(4):1191-1193. PubMed ID: 31166264
[TBL] [Abstract][Full Text] [Related]
3. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of children younger than 24 months with langerhans cell histiocytosis and bone involvement: a report from a single institution.
Kamath S; Arkader A; Jubran RF
J Pediatr Orthop; 2014 Dec; 34(8):825-30. PubMed ID: 25387157
[TBL] [Abstract][Full Text] [Related]
5. [Treatment results of Langerhans cell histiocytosis with LSH II protocol].
Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M
Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702
[TBL] [Abstract][Full Text] [Related]
6. Head and neck manifestation and prognosis of Langerhans' cell histiocytosis in children.
Nicollas R; Rome A; Belaïch H; Roman S; Volk M; Gentet JC; Michel G; Triglia JM
Int J Pediatr Otorhinolaryngol; 2010 Jun; 74(6):669-73. PubMed ID: 20363036
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study.
Ng Wing Tin S; Martin-Duverneuil N; Idbaih A; Garel C; Ribeiro M; Parker JL; Defachelles AS; Lambilliotte A; Barkaoui M; Munzer M; Gardembas M; Sibilia J; Lutz P; Fior R; Polak M; Robert A; Aumaitre O; Plantaz D; Armari-Alla C; Genereau T; Berard PM; Talom GN; Pennaforte JL; Le Pointe HD; Barthez MA; Couillault G; Haroche J; Mokhtari K; Donadieu J; Hoang-Xuan K;
Orphanet J Rare Dis; 2011 Dec; 6():83. PubMed ID: 22151964
[TBL] [Abstract][Full Text] [Related]
8. Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone.
Wang W; Ge J; Ma H; Lian H; Cui L; Zhao Y; Li Z; Wang T; Zhang R
BMC Pediatr; 2024 Jan; 24(1):1. PubMed ID: 38172736
[TBL] [Abstract][Full Text] [Related]
9. Langerhans' cell histiocytosis in adults: a clinical and therapeutic analysis of 11 patients from a single institution.
Giona F; Caruso R; Testi AM; Moleti ML; Malagnino F; Martelli M; Ruco L; Giannetti GP; Annibali S; Mandelli F
Cancer; 1997 Nov; 80(9):1786-91. PubMed ID: 9351548
[TBL] [Abstract][Full Text] [Related]
10. Polyostotic monosystemic calvarial and spinal langerhans' cell histiocytosis treated by surgery and chemotherapy.
Karagoz Guzey F; Bas NS; Emel E; Alatas I; Kebudi R
Pediatr Neurosurg; 2003 Apr; 38(4):206-11. PubMed ID: 12646740
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine therapy for advanced Langerhans cell histiocytosis.
Mahmoud HH; Wang WC; Murphy SB
Blood; 1991 Feb; 77(4):721-5. PubMed ID: 1993215
[TBL] [Abstract][Full Text] [Related]
12. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
Davidson L; McComb JG; Bowen I; Krieger MD
J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
[TBL] [Abstract][Full Text] [Related]
13. Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study.
Duan MH; Han X; Li J; Zhang W; Zhu TN; Han B; Zhuang JL; Wang SJ; Cao XX; Cai HC; Chen M; Yang C; Zhou DB
Leuk Res; 2016 Mar; 42():43-6. PubMed ID: 26859782
[TBL] [Abstract][Full Text] [Related]
14. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients.
Stine KC; Saylors RL; Williams LL; Becton DL
Med Pediatr Oncol; 1997 Oct; 29(4):288-92. PubMed ID: 9251735
[TBL] [Abstract][Full Text] [Related]
15. Approaches to treatment of unifocal langerhans cell histiocytosis: is biopsy alone enough?
Rivera JC; Wylie E; Dell'Orfano S; Mooney R; Hensley MA; Carry P; Monreal AK; Heare T
J Pediatr Orthop; 2014 Dec; 34(8):820-4. PubMed ID: 24590333
[TBL] [Abstract][Full Text] [Related]
16. Vulvar Lesions in an 8-Year-Old Girl: Cutaneous Manifestations of Multisystem Langerhans Cell Histiocytosis.
Jorgensen EM; Chen PP; Rutter S; Cron JA
J Pediatr Adolesc Gynecol; 2018 Apr; 31(2):153-155. PubMed ID: 28993226
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.
Apollonsky N; Lipton JM
J Pediatr Hematol Oncol; 2009 Jan; 31(1):53-6. PubMed ID: 19125089
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal lesion in adult-onset Langerhans cell histiocytosis.
Matsubara Y; Kobayashi M; Hijikata Y; Ota Y; Hirata Y; Lim LA; Yotsuyanagi H; Tojo A
Int J Clin Oncol; 2020 Nov; 25(11):1945-1950. PubMed ID: 32901339
[TBL] [Abstract][Full Text] [Related]
19. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
20. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Gadner H; Minkov M; Grois N; Pötschger U; Thiem E; Aricò M; Astigarraga I; Braier J; Donadieu J; Henter JI; Janka-Schaub G; McClain KL; Weitzman S; Windebank K; Ladisch S;
Blood; 2013 Jun; 121(25):5006-14. PubMed ID: 23589673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
